Catella AB (publ) (CAT-B)
Stockholm Exchange · Sweden · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 15.38 |
|---|---|
| 52-week range | 15.30 – 29.79 |
| Return, 1 month / 3 months | −15.4% / −20.8% |
| Return, 1 year / 3 years | −47.0% / −39.1% |
| Trend | Below its 200-day average |
| RSI (14) | 17 |
| Volatility (1 year) | 30.9% |
| Worst drawdown (1 year) | -48.2% |
| Average daily value traded | 2.17M SEK |
| Dividend yield | 5.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Catella is a Swedish financial group that concentrates on property and asset management. It runs property funds and manages real estate assets for institutional and other investors, and it also provides corporate finance and advisory services related to property and financial transactions. The company is based in Stockholm and works across several European markets, serving clients that include institutions, companies and property owners seeking investment and advisory expertise.
Catella AB (publ) trades under the code CAT-B on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Catella AB (publ) (CAT-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 15.38 on 20 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 582 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 47.0% and over the last three months it fell 20.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -25.3% | ||
| From 52-week high | -48.2% | ||
| Momentum | 20 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.8% | ||
| 6-month return | -29.3% | ||
| 12-month return, skipping the last month | -37.4% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.2% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.17M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −4.9% |
|---|---|
| 1 month | −15.4% |
| 3 months | −20.8% |
| 6 months | −29.3% |
| 1 year | −47.0% |
| 3 years | −39.1% |
| 5 years | −52.5% |
Signals
| 50-day / 200-day average | 17.83 / 20.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 May 2026 | SEK 0.9000 |
| 21 May 2025 | SEK 0.9000 |
| 23 May 2024 | SEK 0.9000 |
| 11 May 2023 | SEK 1.2000 |
| 25 May 2022 | SEK 1.0000 |
| 26 May 2021 | SEK 0.9000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.